Canna~Fangled Abstracts Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation. 2014 May 17. pii: S0165-6147(14)00068-6. doi: 10.1016/j.tips.2014.04.006. Substrate-selective COX-2 inhibition as a novel strategy for…Freedom WaresMay 17, 2014
